TotalMarketCap

Rafael

RFLNYSE United StatesHealth CareBiotechnology: Pharmaceutical Preparations

Market cap

$55.316 M

$1.06 -0.94%

Close of 6 Nov 2026

As of 6 Nov 2026, Rafael (RFL) has a market capitalization of $55.3M. Market cap measures the value of outstanding equity at market prices; company totals combine applicable share classes. Prices and market caps come from Nasdaq, with financial fundamentals from SEC filings. See sources and calculation details.

Revenue

$917.0K

#3464 by revenue

Earnings

-$30.5M

Loss-making

Shares outstanding

—

Latest filing cover page

P/E ratio

—

Cap ÷ net income

Biotechnology: Pharmaceutical Preparations, ranked by market cap

All 498 →
  1. #326Xilio TherapeuticsXLO$55.9M
  2. #327Boundless BioBOLD$55.8M
  3. #328RafaelRFL$55.3M
  4. #329Corbus PharmaceuticalsCRBP$54.8M
  5. #330RenovoRxRNXT$53.9M

What if Rafael were worth as much as…

Open the what-if tool →

Gold $28.2T

$541,095.92

Per share 510,468× higher

Bitcoin $1.53T

$29,277.76

Per share 27,621× higher

Apple $5.02T

$96,116.15

Per share 90,676× higher

Or at a round number

$100.0M$200.0M$500.0M$1.00B

Where these numbers come from

Share counts and financials for Rafael are taken from its own SEC filings via EDGAR: public record, not an estimate. Market cap is shares outstanding multiplied by the latest close. Read the methodology.